Evidence map›Paper›PMID 40818612›Full record

ArticleThe Journal of biological chemistry2025

Degradation of CaMKII is stimulated by its active conformation.

Christina Quasney, Leslie C Griffith

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. ESCRT-0 regulates AMPA receptor currents and CabioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Christina QuasneyDepartment of Biology, Program in Biochemistry and Volen National Center for Complex Systems, Brandeis University, Waltham, Massachusetts, USA.
Leslie C GriffithDepartment of Biology, Program in Biochemistry and Volen National Center for Complex Systems, Brandeis University, Waltham, Massachusetts, USA. Electronic address: griffith@brandeis.edu.

Funding

Activity-Dependent Regulation of CaMKII and Synaptic PlasticityR37NS112810 · NINDS · BRANDEIS UNIVERSITY · PI GRIFFITH, LESLIE C · 2019 to 2025
$2.9M
NINDS NIH HHS R37 NS112810
6 · The paper itself

Abstract

Maintaining synaptic protein levels that support both functional stability and plasticity is crucial for the proper function of the nervous system. Calcium/calmodulin-dependent protein kinase II (CaMKII) plays a pivotal role in synaptic signaling, with its synaptic levels regulated by both activity-dependent translocation from the cytosol and local translation. However, the mechanisms governing the removal of CaMKII from synapses and its degradation remain poorly understood. In this study, we develop a HEK293T cell culture system to investigate what properties of CaMKII regulate its degradation. By isolating distinct conformational states of both Drosophila and rat CaMKII, we demonstrate that locking CaMKII in its active form via a phosphomimetic mutation at the autonomous activation site significantly reduces the half-life for both homologs. We identify ubiquitination as the primary degradation pathway for persistently active CaMKII mutants. Moreover, our findings suggest that the decreased half-life is primarily due to the exposure of the catalytic and regulatory domains, rather than changes in the oligomerization state of the holoenzyme or regulation of degradation pathways by the kinase's enzymatic activity. These results provide a template for understanding CaMKII degradation in neurons.

Indexed as

Calcium-Calmodulin-Dependent Protein Kinase Type 2Drosophila ProteinsProteolysisAnimalsDrosophila melanogasterHalf-LifeHEK293 CellsHumansMutationProtein ConformationRatsUbiquitinationCalcium-Calmodulin-Dependent Protein Kinase Type 2Drosophila ProteinsautophosphorylationCa2+/calmodulin-dependent protein kinase II (CaMKII)DrosophilaHEK293T cellsprotein degradationubiquitin

Identifiers

PMID40818612
PMCPMC12624777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.